Affinity DataKd: 0.480nMAssay Description:Displacement of 0.1 nM [125I]CCL2 from human CCR2 expressing human U2OS cell membrane by scintillation spectrometryMore data for this Ligand-Target Pair
Affinity DataKd: 3.47nMAssay Description:Antagonist activity at human CCR2 in human peripheral whole blood assessed as inhibition of MCP1-induced L-selectin sheddingMore data for this Ligand-Target Pair
Affinity DataKd: 251nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 398nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 398nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 398nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 398nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 501nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 501nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 631nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 1.00E+3nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 1.26E+3nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 1.58E+3nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 2.51E+3nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 3.16E+3nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 3.98E+3nMAssay Description:Antagonist activity at CCR2 receptor in human whole blood assessed as inhibition of MCP-1 induced monocyte shape change pretreated for 15 mins before...More data for this Ligand-Target Pair
Affinity DataKd: 1.00E+4nMAssay Description:Antagonist activity at CCR2 in human whole blood assessed as inhibition of CCL2-stimulated monocyte shape changeMore data for this Ligand-Target Pair